{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:17:40Z","timestamp":1762323460390},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s12272-011-1118-8","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T05:40:01Z","timestamp":1322890801000},"page":"1973-1982","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacokinetics of carbamazepine polymorphs and dihydrate in rats, related to dogs and humans"],"prefix":"10.1007","volume":"34","author":[{"given":"Caihong","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,3]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1099-0801(199701)11:1<36::AID-BMC622>3.0.CO;2-1","volume":"11","author":"M. M. Alexishvili","year":"1997","unstructured":"Alexishvili, M. M., Rukhadze, M. D., and Okujava, V. M., Simultaneous determination of carbamazepine and carbamazepine 10,11-epoxide by using microcolumn HPLC: study of pharmacokinetics of carbamazepine in a volunteer. Biomed. Chromatogr., 11, 36\u201341 (1997).","journal-title":"Biomed. Chromatogr."},{"key":"1118_CR2","first-page":"307","volume":"9","author":"M. Barzegar-Jalali","year":"2006","unstructured":"Barzegar-Jalali, M., Nayebi, A. M., Valizadeh, H., Hanaee, J., Barzegar-Jalali, A., Adibkia, K., Anoush, M., and Sistanizad, M., Evaluation of in vitro-in vivo correlation and anticonvulsive effect of carbamazepine after cogrinding with microcrystalline cellulose. J. Pharm. Pharm. Sci., 9, 307\u2013316 (2006).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"1118_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jps.20495","volume":"95","author":"S. R. Carino","year":"2006","unstructured":"Carino, S. R., Sperry, D. C., and Hawley, M., Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J. Pharm. Sci., 95, 116\u2013125 (2006).","journal-title":"J. Pharm. Sci."},{"key":"1118_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00561065","volume":"12","author":"L. M. Cotter","year":"1977","unstructured":"Cotter, L. M., Eadie, M. J., Hooper, W. D., Lander, C. M., Smith, G. A., and Tyrer, J. H., The pharmacokinetics of carbamazepine. Eur. J. Clin. Pharmacol., 12, 451\u2013456 (1977).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"1118_CR5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1023\/A:1016020709678","volume":"68","author":"A. Cvetkovskii","year":"2002","unstructured":"Cvetkovskii, A., Bettini, R., Tasic, Lj., Stupar, M., Casini, I., Rossi, A., and Giordano, F., Thermal properties of binary mixtures of \u03b2-cyclodextrin with carbamazepine polymorphs. J. Therm. Anal. Calorim., 68, 669\u2013678 (2002).","journal-title":"J. Therm. Anal. Calorim."},{"key":"1118_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1016353705970","volume":"3","author":"J. B. Dressman","year":"1986","unstructured":"Dressman, J. B., Comparison of canine and human gastrointestinal physiology. Pharm. Res., 3, 123\u2013131 (1986).","journal-title":"Pharm. Res."},{"key":"1118_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00562659","volume":"8","author":"M. Eichelbaum","year":"1975","unstructured":"Eichelbaum, M., Ekbom, K., Bertilsson, L., Ringberger, V. A., and Rane, A., Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur. J. Clin. Pharmacol., 8, 337\u2013341 (1975).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"1118_CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1773-2247(04)50027-8","volume":"14","author":"R. Elqidra","year":"2004","unstructured":"Elqidra, R., \u00dcnl\u00fc, N., \u00c7apan, Y., Sahin, G., Dalkara, T., and H\u00fdncal, A. A., Effect of polymorphism on in vitro \u2014 in vivo properties of carbamazepine conventional tablets. J. Drug Del. Sci. Tech., 14, 147\u2013153 (2004).","journal-title":"J. Drug Del. Sci. Tech."},{"key":"1118_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1542\/peds.107.1.176","volume":"107","author":"A. Fleischman","year":"2001","unstructured":"Fleischman, A. and Chiang, V. W., Carbamazepine overdose recognized by a tricyclic antidepressant assay. Pediatrics, 107, 176\u2013177 (2001).","journal-title":"Pediatrics"},{"key":"1118_CR10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1528-1157.1990.tb05384.x","volume":"31","author":"A. G\u00e9rardin","year":"1990","unstructured":"G\u00e9rardin, A., Dubois, J. P., Moppert, J., and Geller, L., Absolute bioavailability of carbamazepine after oral administration of a 2% syrup. Epilepsia, 31, 334\u2013338 (1990).","journal-title":"Epilepsia"},{"key":"1118_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0378-5173(02)00649-X","volume":"252","author":"P. M. Gosselin","year":"2003","unstructured":"Gosselin, P. M., Thibert, R., Preda, M., and McMullen, J. N., Polymorphic properties of micronized carbamazepine produced by RESS. Int. J. Pharm., 252, 225\u2013233 (2003).","journal-title":"Int. J. Pharm."},{"key":"1118_CR12","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/jps.10455","volume":"92","author":"A. L. Grzesiak","year":"2003","unstructured":"Grzesiak, A. L., Lang, M., Kim, K., and Matzger, A. J., Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J. Pharm. Sci., 92, 2260\u20132271 (2003).","journal-title":"J. Pharm. Sci."},{"key":"1118_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2006.12.016","volume":"67","author":"M. B. Hickey","year":"2007","unstructured":"Hickey, M. B., Peterson, M. L., Scoppettuolo, L. A., Morrisette, S. L., Vetter, A., Guzm\u00e1n, H., Remenar, J. F., Zhang, Z., Tawa, M. D., Haley, S., Zaworotko, M. J., and Almarsson, O., Performance comparison of a co-crystal of carbamazepine with marketed product. Eur. J. Pharm. Biopharm., 67, 112\u2013119 (2007).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1118_CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1081\/DMR-120026870","volume":"35","author":"J. B. Houston","year":"2003","unstructured":"Houston, J. B. and Galetin, A., Progress towards prediction of human pharmacokinetic parameters from in vitro technologies. Drug Metab. Rev., 35, 393\u2013415 (2003).","journal-title":"Drug Metab. Rev."},{"key":"1118_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(83)90118-7","volume":"14","author":"P. Kahela","year":"1983","unstructured":"Kahela, P., Aaltonen, R., Lewing, E., Anttila, M., and Kristoffersson, E., Pharmacokinetics and dissolution of two crystalline forms of carbamazepine. Int. J. Pharm., 14, 103\u2013112 (1983).","journal-title":"Int. J. Pharm."},{"key":"1118_CR16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1248\/yakushi1947.104.2_184","volume":"104","author":"N. Kaneniwa","year":"1984","unstructured":"Kaneniwa, N., Yamaguchi, T., Watari, N., and Otsuka, M., Hygroscopicity of carbamazepine crystalline powders. Yakugaku Zasshi, 104, 184\u2013190 (1984).","journal-title":"Yakugaku Zasshi"},{"key":"1118_CR17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1248\/yakushi1947.107.10_808","volume":"107","author":"N. Kaneniwa","year":"1987","unstructured":"Kaneniwa, N., Ichikawa, J., Yamaguchi, T., Hayashi, K., Watari, N., and Sumi, M., Dissolution behaviour of carba-mazepine polymorphs. Yakugaku Zasshi, 107, 808\u2013813 (1987).","journal-title":"Yakugaku Zasshi"},{"key":"1118_CR18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","volume":"16","author":"T. T. Kararli","year":"1995","unstructured":"Kararli, T. T., Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos., 16, 351\u2013380 (1995).","journal-title":"Biopharm. Drug Dispos."},{"key":"1118_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(99)00315-4","volume":"193","author":"Y. Kobayashi","year":"2000","unstructured":"Kobayashi, Y., Ito, S., Itai, S., and Yamamoto, K., Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int. J. Pharm., 193, 137\u2013146 (2000).","journal-title":"Int. J. Pharm."},{"key":"1118_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejps.2004.03.010","volume":"22","author":"L. S. Koester","year":"2004","unstructured":"Koester, L. S., Bertuol, J. B., Groch, K. R., Xavier, C. R., Moellerke, R., Mayorga, P., Dalla Costa, T., and Bassani, V. L., Bioavailability of carbamazepine:beta-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets. Eur. J. Pharm. Sci., 22, 201\u2013207 (2004).","journal-title":"Eur. J. Pharm. Sci."},{"key":"1118_CR21","first-page":"S111","volume":"17S","author":"E. S. Kostewicz","year":"2002","unstructured":"Kostewicz, E. S., Carlsson, A. S., Hanisch, G., Nilsson, R. G., L\u00d6fgren, L., and Abrahamsson, B., Comparison of dog and human intestinal fluid and its impact on solubility estimations. Eur. J. Pharm. Sci., 17(S), S111\u2013S132 (2002).","journal-title":"Eur. J. Pharm. Sci."},{"key":"1118_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2011.02.042","volume":"409","author":"W. Kou","year":"2011","unstructured":"Kou, W., Cai, C., Xu, S., Wang, H., Liu, J., Yang, D., and Zhang, T., In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-\u03b2-cyclodextrin in the presence of HPMC. Int. J. Pharm., 409, 75\u201380 (2011).","journal-title":"Int. J. Pharm."},{"key":"1118_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/mp800128y","volume":"6","author":"I. Kovac\u00ecvi\u00e6","year":"2009","unstructured":"Kovac\u00ecvi\u00e6, I., Paroj\u00e8i\u00e6, J., Homs\u00eck, I., Tubi\u00e6-Grozdanis, M., and Langguth, P., Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation. Mol. Pharm., 6, 40\u201347 (2009).","journal-title":"Mol. Pharm."},{"key":"1118_CR24","first-page":"247","volume":"62","author":"F. U. Krahn","year":"1987","unstructured":"Krahn, F. U. and Mielck, J. B., Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm. Acta Helv., 62, 247\u2013254 (1987).","journal-title":"Pharm. Acta Helv."},{"key":"1118_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0939-6411(99)00016-8","volume":"48","author":"O. A. Lake","year":"1999","unstructured":"Lake, O. A., Olling, M., and Barends, D. M., In vitro\/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Eur. J. Pharm. Biopharm., 48, 13\u201319 (1999).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1118_CR26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02975147","volume":"28","author":"H. Lee","year":"2005","unstructured":"Lee, H., Park, S. A., and Sah, H., Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet. Arch. Pharm. Res., 28, 120\u2013126 (2005).","journal-title":"Arch. Pharm. Res."},{"key":"1118_CR27","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3109\/03639048609042617","volume":"12","author":"C. Lefebvre","year":"1986","unstructured":"Lefebvre, C., Guyot-Hermann, A. M., Draguet-Brughmans, M., Bouch\u00e9, R., and Guyot, J. C., Polymorphic transitions of carbamazepine during grinding and compression. Drug Dev. Ind. Pharm., 12, 1913\u20131927 (1986).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"1118_CR28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jps.21490","volume":"98","author":"P. Lehto","year":"2009","unstructured":"Lehto, P., Aaltonen, J., Tenho, M., Rantanen, J., Hirvonen, J., Tanninen, V. P., and Peltonen, L., Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid. J. Pharm. Sci., 98, 985\u2013996 (2009).","journal-title":"J. Pharm. Sci."},{"key":"1118_CR29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jps.2600760914","volume":"76","author":"M. M. Lowes","year":"1987","unstructured":"Lowes, M. M., Caira, M. R., L\u00f6tter, A. P., and Van der Watt, J. G., Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J. Pharm. Sci., 76, 744\u2013752 (1987).","journal-title":"J. Pharm. Sci."},{"key":"1118_CR30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1021\/js960117e","volume":"85","author":"L. E. McMahon","year":"1996","unstructured":"McMahon, L. E., Timmins, P., Williams, A. C., and York, P., Characterization of dihydrates prepared from carbamazepine polymorphs. J. Pharm. Sci., 85, 1064\u20131069 (1996).","journal-title":"J. Pharm. Sci."},{"key":"1118_CR31","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1023\/A:1015872626887","volume":"9","author":"M. C. Meyer","year":"1992","unstructured":"Meyer, M. C., Straughn, A. B., Jarvi, E. J., Wood, G. C., Pelsor, F. R., and Shah, V. P., The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm. Res., 9, 1612\u20131616 (1992).","journal-title":"Pharm. Res."},{"key":"1118_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03602537508993750","volume":"4","author":"P. L. Morselli","year":"1975","unstructured":"Morselli, P. L. and Frigerio, A., Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab. Rev., 4, 97\u2013113 (1975).","journal-title":"Drug Metab. Rev."},{"key":"1118_CR33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-5173(02)00083-2","volume":"240","author":"R. Nair","year":"2002","unstructured":"Nair, R., Gonen, S., and Hoag, S. W., Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int. J. Pharm., 240, 11\u201322 (2002).","journal-title":"Int. J. Pharm."},{"key":"1118_CR34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jcrysgro.2004.10.158","volume":"274","author":"A. Nokhodchi","year":"2005","unstructured":"Nokhodchi, A., Bolourtchian, N., and Dinarvand, R., Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives. J. Cryst. Growth, 274, 573\u2013584 (2005).","journal-title":"J. Cryst. Growth"},{"key":"1118_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00007-8","volume":"239","author":"M. Ono","year":"2002","unstructured":"Ono, M., Tozuka, Y., Oguchi, T., Yamamura, S., and Yamamoto, K., Effects of dehydration temperature on water vapor adsorption and dissolution behavior of carbamazepine. Int. J. Pharm., 239, 1\u201312 (2002).","journal-title":"Int. J. Pharm."},{"key":"1118_CR36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00007691-197901030-00014","volume":"1","author":"S. Pynn\u00f6nen","year":"1979","unstructured":"Pynn\u00f6nen, S., Pharmacokinetics of Carbamazepine in man: a review. Ther. Drug Monit., 1, 409\u2013431 (1979).","journal-title":"Ther. Drug Monit."},{"key":"1118_CR37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1015872901523","volume":"7","author":"R. P. Remmel","year":"1990","unstructured":"Remmel, R. P., Sinz, M. W., and Cloyd, J. C., Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide. Pharm. Res., 7, 513\u2013517 (1990).","journal-title":"Pharm. Res."},{"key":"1118_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0928-0987(99)00065-2","volume":"9","author":"R. J. Roberts","year":"2000","unstructured":"Roberts, R. J., Payne, R. S., and Rowe, R. C., Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine. Eur. J. Pharm Sci., 9, 277\u2013283 (2000).","journal-title":"Eur. J. Pharm Sci."},{"key":"1118_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0731-7085(00)00262-4","volume":"23","author":"C. Rustichelli","year":"2000","unstructured":"Rustichelli, C., Gamberini, G., Ferioli, V., Gamberini, M. C., Ficarra, R., and Tommasini, S., Solid-state study of polymorphic drugs: carbamazepine. J. Pharm. Biomed. Anal., 23, 41\u201354 (2000).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"1118_CR40","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jps.20532","volume":"95","author":"A. K. Salameh","year":"2006","unstructured":"Salameh, A. K. and Taylor, L. S., Physical stability of crystal hydrates and their anhydrates in the presence of excipients. J. Pharm. Sci., 95, 446\u2013461 (2006).","journal-title":"J. Pharm. Sci."},{"key":"1118_CR41","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3109\/00498250903254340","volume":"39","author":"L. M. Sanftner","year":"2009","unstructured":"Sanftner, L. M., Gibbons, J. A., Gross, M. I., Suzuki, B. M., Gaeta, F. C., and Johnson, K. W., Cross-species comparisons of the pharmacokinetics of ibudilast. Xenobiotica, 39, 964\u2013977 (2009).","journal-title":"Xenobiotica"},{"key":"1118_CR42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2009.10.051","volume":"386","author":"S. Sehi\u00e6","year":"2010","unstructured":"Sehi\u00e6, S., Betz, G., Hadzidedi\u00e6, S., El-Arini, S. K., and Leuenberger, H., Investigation of intrinsic dissolution behavior of different carbamazepine samples. Int. J. Pharm., 386, 77\u201390 (2010).","journal-title":"Int. J. Pharm."},{"key":"1118_CR43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.addr.2003.10.008","volume":"56","author":"D. Singhal","year":"2004","unstructured":"Singhal, D. and Curatolo, W., Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Deliv. Rev., 56, 335\u2013347 (2004).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1118_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1099-081X(200001)21:1<1::AID-BDD207>3.0.CO;2-D","volume":"21","author":"P. Veng-Pedersen","year":"2000","unstructured":"Veng-Pedersen, P., Gobburu, J. V., Meyer, M. C., and Straughn, A. B., Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach. Biopharm. Drug Dispos., 21, 1\u20136 (2000).","journal-title":"Biopharm. Drug Dispos."},{"key":"1118_CR45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.1991.tb03954.x","volume":"32","author":"I. R. Wilding","year":"1991","unstructured":"Wilding, I. R., Davis, S. S., Hardy, J. G., Robertson, C. S., John, V. A., Powell, M. L., Leal, M., Lloyd, P., and Walker, SM., Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release sys tem and as a suspension of 15N-labelled drug to healthy volunteers. Br. J. Clin. Pharmacol., 32, 573\u2013579 (1991).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1118_CR46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1081\/CLT-120015836","volume":"40","author":"R. I. Winnicka","year":"2002","unstructured":"Winnicka, R. I., Topaci\u00f1ski, B., Szymczak, W. M., and Szyma\u00f1ska, B., Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. J. Toxicol. Clin. Toxicol., 40, 759\u2013765 (2002).","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"1118_CR47","unstructured":"Zhang, Y. P., Pharmacological experiment. 2nd ed. People\u2019s Medical Publishing House, p. 283, (1996)."},{"key":"1118_CR48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10549-010-0999-4","volume":"122","author":"L. Zhou","year":"2010","unstructured":"Zhou, L., Jiang, Y., Yan, T., Di, G., Shen, Z., Shao, Z., and Lu, J., The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures. Breast Cancer Res. Treat., 122, 795\u2013801 (2010).","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-011-1118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-011-1118-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-011-1118-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T12:22:57Z","timestamp":1559564577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-011-1118-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1007\/s12272-011-1118-8","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}